Xiuning Le

Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations

Paul K. Paik, Enriqueta Felip, Rémi Veillon et al. · New England Journal of Medicine · 2020 · 819 citations · Full text

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 582 citations · Full text

Neostar Trial, Medicine, Immune Checkpoint Inhibitor +6

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

Yanshuo Chu, Enyu Dai, Yating Li et al. · Nature Medicine · 2023 · 418 citations · Full text

Cancer Immunosurveillance, T-regulatory Cell, Immunology +10

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Jacqulyne Robichaux, Xiuning Le, R.S.K. Vijayan et al. · Nature · 2021 · 416 citations · Full text

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <i>EGFR</i> -Mutant NSCLC

Xiuning Le, Sonam Puri, Marcelo V. Negrão et al. · Clinical Cancer Research · 2018 · 378 citations